4.6 Article

Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations

Journal

HUMAN GENETICS
Volume 137, Issue 11-12, Pages 921-939

Publisher

SPRINGER
DOI: 10.1007/s00439-018-1957-1

Keywords

Juvenile segmental progeroid syndrome; Hutchinson-Gilford progeria syndrome; Wiedemann-Rautenstrauch progeroid syndrome; POLR3A; PYCR1

Funding

  1. (Forschungsforderungsfonds der Medizinischen Fakultat der Universitatsklinikum Hamburg-Eppendorf [FFM])
  2. Deutsche Forschungsgemeinschaft [LE4223/1-1]
  3. University of Michigan Center for Genomics in Health and Disease
  4. Progeria Research Foundation
  5. National Human Genome Research Institute
  6. National Heart, Lung and Blood Institute [2UM1HG006493]
  7. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Juvenile segmental progeroid syndromes are rare, heterogeneous disorders characterized by signs of premature aging affecting more than one tissue or organ starting in childhood. Hutchinson-Gilford progeria syndrome (HGPS), caused by a recurrent de novo synonymous LMNA mutation resulting in aberrant splicing and generation of a mutant product called progerin, is a prototypical example of such disorders. Here, we performed a joint collaborative study using massively parallel sequencing and targeted Sanger sequencing, aimed at delineating the underlying genetic cause of 14 previously undiagnosed, clinically heterogeneous, non-LMNA-associated juvenile progeroid patients. The molecular diagnosis was achieved in 11 of 14 cases (similar to 79%). Furthermore, we firmly establish biallelic mutations in POLR3A as the genetic cause of a recognizable, neonatal, Wiedemann-Rautenstrauch-like progeroid syndrome. Thus, we suggest that POLR3A mutations are causal for a portion of under-diagnosed early-onset segmental progeroid syndromes. We additionally expand the clinical spectrum associated with PYCR1 mutations by showing that they can somewhat resemble HGPS in the first year of life. Moreover, our results lead to clinical reclassification in one single case. Our data emphasize the complex genetic and clinical heterogeneity underlying progeroid disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available